Versant Capital Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$438K Sell
10,275
-2,721
-21% -$122K 0.04% 336
2026
Q1
$626K Buy
12,996
+2,938
+29% +$137K 0.06% 210
2025
Q4
$487K Sell
10,058
-1,340
-12% -$66.4K 0.06% 226
2025
Q3
$538K Buy
11,398
+2,219
+24% +$107K 0.07% 181
2025
Q2
$443K Sell
9,179
-1,208
-12% -$61.7K 0.07% 208
2025
Q1
$576K Buy
10,387
+9,271
+831% +$502K 0.1% 125
2024
Q4
$53.8K Buy
+1,116
New +$56.7K 0.01% 559
2023
Q4
Sell
-103
Closed -$5.53K 2007
2023
Q3
$5.53K Hold
103
﹤0.01% 945
2023
Q2
$5.55K Hold
103
﹤0.01% 1001
2023
Q1
$5.61K Buy
+103
New +$5.01K ﹤0.01% 905
2018
Q1
Sell
-76
Closed -$3K 1638
2017
Q4
$3K Buy
+76
New +$3.5K ﹤0.01% 1270
2016
Q4
Sell
-105
Closed -$4.14K 1512
2016
Q3
$4K Sell
105
-700
-87% -$28.1K ﹤0.01% 1061
2016
Q2
$33K Hold
805
0.02% 367
2016
Q1
$32K Buy
805
+105
+15% +$4.22K 0.02% 360
2015
Q4
$29K Buy
+700
New +$32.2K 0.02% 387

Other funds holding SNY

Versant Capital Management's SNY Position: Q2 2026 in Review

Versant Capital Management reduced its Sanofi (SNY) stake by 21% in Q2 2026, selling an estimated $122K and leaving 10,275 shares worth $438K. The position accounts for 0.04% of the portfolio, ranked #336.

Versant Capital Management first reported a position in SNY in Q4 2015 and has held it in 15 quarters since. The position peaked at $626K in Q1 2026. 128 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Versant Capital Management held 10,275 shares of Sanofi worth $438K as of Q2 2026.
  • Versant Capital Management sold 2,721 Sanofi shares in Q2 2026, an estimated $122K.
  • Sanofi made up 0.04% of Versant Capital Management's portfolio in Q2 2026, its #336 holding.
  • Versant Capital Management first reported a position in Sanofi in Q4 2015 and has held it in 15 quarters since.
  • Versant Capital Management's Sanofi position peaked at $626K in Q1 2026.
  • 128 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.